hoxd10a Antibody

What is HOXD10 and what cellular functions does it regulate?

HOXD10 functions as a sequence-specific transcription factor within a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis . The protein is strongly expressed in the adult male and female urogenital tracts . As a homeobox protein, HOXD10 plays critical roles in embryonic development and pattern formation.

For researchers studying HOXD10, it's important to understand that the protein localizes primarily to the nucleus, as confirmed by immunofluorescence studies showing specific nuclear staining in neural progenitor cells derived from human induced pluripotent stem cells . This nuclear localization is consistent with its function as a transcription factor that regulates gene expression programs.

What experimental applications are most effective for HOXD10 antibody usage?

Based on validated research protocols, HOXD10 antibodies have demonstrated effectiveness in multiple applications:

When designing experiments, researchers should consider that optimal dilutions may need to be determined empirically for each specific application and sample type. Preliminary titration experiments are recommended to establish optimal signal-to-noise ratios for your specific experimental system .

How can I validate HOXD10 antibody specificity for my research?

Antibody validation is crucial for ensuring reliable experimental results. For HOXD10 antibodies, consider implementing these methodological approaches:

• Positive and negative control samples: Use tissues or cell lines known to express HOXD10 (e.g., HeLa cells, fetal heart tissue) versus those with minimal expression .

• Molecular weight verification: Confirm the detection of bands at the expected molecular weight (approximately 38 kDa) in Western blot applications .

• Knockout/knockdown controls: When possible, use HOXD10 knockout or knockdown samples as negative controls to confirm antibody specificity.

• Cross-reactivity assessment: If working across species, verify the sequence homology and test the antibody in multiple species when applicable. Current antibodies have been validated in human samples, with predicted reactivity to other species including pig, bovine, horse, sheep, and rabbit based on sequence alignment analysis .

• Co-localization studies: For ICC/IF applications, co-stain with established markers. For example, HOXD10 should co-localize with nuclear markers (DAPI) but not cytoplasmic markers like Nestin .

How can I optimize co-localization studies with HOXD10 antibodies?

Co-localization studies require careful optimization to obtain reliable results. For HOXD10, consider these advanced methodological approaches:

HOXD10 was successfully co-stained with Nestin in neural progenitor cells, revealing distinct localization patterns with HOXD10 in the nucleus and Nestin in the cytoplasm . To replicate this approach:

• Fixation optimization: Use immersion fixation for preserving cellular architecture while maintaining epitope accessibility.

• Sequential antibody application: Apply primary antibodies from different host species (e.g., Goat Anti-Human HOXD10 with Mouse Anti-Human Nestin) at optimized concentrations (10 μg/mL has been validated) .

• Incubation parameters: Conduct primary antibody incubation for 3 hours at room temperature for optimal penetration and binding .

• Secondary antibody selection: Use spectrally distinct fluorophores (e.g., NorthernLights™ 557 for HOXD10 and NorthernLights™ 493 for co-markers) to clearly distinguish signals .

• Nuclear counterstaining: Include DAPI counterstaining to confirm the nuclear localization of HOXD10 .

This methodological approach allows for clear differentiation between nuclear HOXD10 localization and other cellular compartment markers, enabling precise spatial characterization of protein expression and interactions.

What are the critical considerations when investigating HOXD10 in inflammatory disease models?

Recent research has revealed HOXD10's significant role in inflammatory conditions, particularly ulcerative colitis (UC). When designing studies investigating HOXD10 in inflammation:

• Expression baseline establishment: HOXD10 is downregulated in UC samples and significantly decreased by dextran sulfate sodium (DSS) administration in experimental models .

• Functional assessment approaches: When overexpressing HOXD10, measure multiple functional outcomes including:

  • Weight loss dynamics

  • Disease activity index values

  • Colon length measurements

  • Cell apoptosis (TUNEL assay)

  • Cell proliferation (Ki-67 immunoreactivity)

  • Inflammatory marker expression (TNF-α, IL-6, IL-1β)

• Mechanism investigation: Examine the Rho/ROCK/MMPs axis activity, as HOXD10 has been shown to suppress this pathway in colon tissues of UC models .

• Barrier function assessment: Include intestinal permeability measurements to evaluate HOXD10's role in maintaining barrier function, which appears to be a key mechanism in its protective effects against inflammation .

These methodological considerations provide a comprehensive experimental framework for investigating HOXD10's role in inflammatory conditions, moving beyond correlative observations to functional and mechanistic insights.

How should researchers approach tissue-specific expression analysis of HOXD10?

HOXD10 exhibits tissue-specific expression patterns that must be considered when designing experiments:

• Baseline expression mapping: HOXD10 is strongly expressed in adult male and female urogenital tracts, providing important positive control tissues .

• Developmental stage considerations: As a homeobox protein involved in developmental patterning, HOXD10 expression varies across developmental stages, requiring careful timing of sample collection.

• Multi-technique validation approach:

  • Western blot analysis in tissue lysates (validated in fetal heart, adult heart tissues)

  • Immunohistochemistry for spatial distribution within tissues

  • qRT-PCR for quantitative expression assessment across multiple tissues

• Species-specific considerations: When conducting comparative studies across species, researchers should note that while the antibodies have confirmed reactivity in human and mouse samples, predictions for other species (pig, bovine, horse, sheep, rabbit) are based on sequence homology and require experimental validation .

A comprehensive tissue expression analysis should incorporate multiple methodological approaches to establish both the quantitative levels and spatial distribution patterns of HOXD10 across tissues of interest.

How can researchers troubleshoot inconsistent HOXD10 antibody performance?

When encountering technical challenges with HOXD10 antibodies, implement these systematic troubleshooting approaches:

• Western blot inconsistencies:

  • Verify protein denaturation conditions, as tertiary structure may affect epitope accessibility

  • Optimize transfer conditions for the 38 kDa HOXD10 protein

  • Validate blocking reagents to minimize background

  • Test multiple antibody concentrations, starting with validated dilutions (1/1000 for Western blot)

• Immunofluorescence signal variability:

  • Optimize fixation methods for nuclear antigen preservation

  • Evaluate permeabilization protocols to ensure nuclear access

  • Adjust antibody concentration (10 μg/mL has been validated)

  • Compare counterstaining patterns with DAPI to confirm nuclear localization

• Flow cytometry challenges:

  • Ensure complete cell permeabilization for nuclear antigen access

  • Validate compensation settings for multicolor analysis

  • Compare results with isotype controls (e.g., rabbit IgG negative)

  • Test different fixation methods if signal intensity is low

Methodical approach to troubleshooting, with systematic evaluation of each experimental variable, will help resolve inconsistencies and establish reliable protocols for HOXD10 detection across applications.

What methodological approaches can resolve contradictory data in HOXD10 research?

When facing contradictory results in HOXD10 studies, implement these resolution strategies:

• Antibody cross-validation:

  • Compare results using multiple antibodies targeting different HOXD10 epitopes

  • Validate with both polyclonal (AF9089) and monoclonal (ab138508) antibodies to confirm findings

  • Ensure antibodies recognize the appropriate species variants

• Transcript-protein correlation analysis:

  • Combine mRNA expression analysis (qRT-PCR) with protein detection methods

  • Evaluate potential post-transcriptional regulation affecting protein levels

  • Consider temporal dynamics between transcript and protein expression

• Functional validation approaches:

  • Implement gene silencing or overexpression to confirm antibody specificity and biological functions

  • Assess downstream targets or interacting proteins to validate pathway involvement

  • Correlate experimental findings with disease phenotypes, such as UC symptoms in HOXD10 studies

• Technical parameter standardization:

  • Document and standardize critical experimental parameters

  • Create detailed protocols that specify reagent concentrations, incubation times, and equipment settings

  • Establish positive and negative controls for each experimental approach

Resolving contradictory data requires a multi-faceted approach that combines technical validation, independent methodologies, and functional assessments to establish reliable and reproducible findings.

What emerging applications for HOXD10 antibodies should researchers consider?

Based on recent advancements, researchers should consider these innovative applications for HOXD10 antibodies:

• Single-cell analysis integration:

  • Combine HOXD10 antibodies with single-cell technologies to map expression heterogeneity

  • Integrate with spatial transcriptomics to correlate protein localization with transcriptional landscapes

  • Develop computational approaches to link HOXD10 expression patterns with cell fate decisions

• Therapeutic target validation:

  • Utilize HOXD10 antibodies to validate therapeutic approaches targeting the Rho/ROCK/MMPs pathway in inflammatory conditions

  • Implement in high-throughput screening assays to identify compounds that modulate HOXD10 expression or activity

  • Develop companion diagnostic approaches for potential HOXD10-targeted therapies

• Multiparameter imaging applications:

  • Expand co-localization studies beyond Nestin to include additional markers of developmental pathways

  • Implement multiplex immunofluorescence to simultaneously visualize HOXD10 with interacting proteins

  • Combine with live-cell imaging to track dynamic changes in HOXD10 localization during cellular processes

• Predictive biomarker development:

  • Evaluate HOXD10 as a potential biomarker for inflammatory conditions like ulcerative colitis

  • Correlate expression levels with disease severity and treatment response

  • Develop standardized quantification methods for clinical application

These emerging applications represent the frontier of HOXD10 research, leveraging antibody-based detection methods to explore fundamental biological questions and develop potential clinical applications.

How can researchers integrate HOXD10 studies into broader developmental and disease contexts?

To position HOXD10 research within wider biological frameworks, consider these integrative approaches:

• Developmental pathway mapping:

  • Characterize HOXD10's interaction with other homeobox genes during development

  • Map temporal expression patterns across embryonic stages

  • Correlate with cell fate decisions and positional identity establishment on the anterior-posterior axis

• Disease mechanism integration:

  • Expand beyond UC to investigate HOXD10's role in other inflammatory and developmental disorders

  • Examine potential connections between developmental roles and disease manifestations

  • Integrate with systems biology approaches to understand network effects

• Comparative evolutionary analysis:

  • Utilize antibodies with cross-species reactivity to examine conservation of HOXD10 functions

  • Compare expression patterns and regulatory mechanisms across species

  • Develop evolutionary models of homeobox gene specialization

• Multi-omics integration strategies:

  • Combine antibody-based protein detection with transcriptomics, epigenomics, and proteomics

  • Identify regulatory networks controlling HOXD10 expression

  • Map downstream effectors mediating HOXD10's impact on cellular processes

By implementing these integrative approaches, researchers can position HOXD10 studies within broader biological contexts, revealing fundamental principles of development and disease while identifying potential therapeutic targets.